New Delhi [India], June 2: Reinforcing its commitment to pioneering advanced cancer care, Sarvodaya Hospital, Faridabad, Delhi NCR is proud to announce that it has become the first Theranostics and Nuclear Medicine center in India to offer Terbium-161 PSMA therapy for prostate cancer treatme
Mumbai (Maharashtra) [India], December 20: Servier India has introduced its oncology portfolio with the launch of Onivyde® (nanoliposomal irinotecan) for metastatic pancreatic cancer. This launch aligns with Servier's commitment to providing therapies for hard-to-treat cancers, with an
The majority of cancer deaths are caused by metastatic disease, which occurs when cancer spreads from the primary tumour to other areas of the body. and researchers understand how cancer cells escape the primary location to seed new tumours, it is unclear why some cancer cells produce new t
Long-term data from a landmark international trial show that about half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibitors live cancer-free for 10 years or more, according to a new report from Weill Cornell Medicine and Dana-Farber Cancer Centre i
According to a new report from Weill Cornell Medicine and Dana-Farber Cancer Centre investigators and their colleagues, long-term data from a landmark international trial show that approximately half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibit
In a significant stride towards combating metastatic breast cancer, Israeli researchers unveiled a novel therapeutic approach utilizing already-existing medications that offers hope for improved survival rates.
Researcher Paul Dent of Virginia Commonwealth University's Department of Biochemistry and Molecular Biology found that tumours that have metastasized to distant locations, such as the brain, are most often impossible to treat and cure, despite recent successes in some tumour types such as NS
The body's lymph nodes serve as one of its first lines of defence against sickness. From these biological police stations, immune cells are sent out to repel invaders. However, the majority of metastatic tumours also start in lymph nodes.
The researchers discovered that many long-term Covid patients were extremely unwell and had fatigue scores that were worse or comparable to persons with cancer-related anaemia or severe kidney impairment. They also had lower health-related quality of life scores than those with advanced meta
Researchers discovered that 42 percent of patients with metastatic brain cancer benefited from the immune checkpoint inhibitor pembrolizumab in a phase 2 clinical study, with seven patients living for more than two years. The authors emphasise that these advantages must be balanced against t